Literature DB >> 12221032

Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease.

J A Eaden1, J F Mayberry.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12221032      PMCID： PMC1867735          DOI： 10.1136/gut.51.suppl_5.v10

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  42 in total

1.  Colorectal cancer prevention in ulcerative colitis: a case-control study.

Authors:  J Eaden; K Abrams; A Ekbom; E Jackson; J Mayberry
Journal:  Aliment Pharmacol Ther       Date:  2000-02       Impact factor: 8.171

2.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

3.  Cancer risk and life expectancy of children with ulcerative colitis.

Authors:  G J Devroede; W F Taylor; W G Sauer; R J Jackman; G B Stickler
Journal:  N Engl J Med       Date:  1971-07-01       Impact factor: 91.245

4.  Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis.

Authors:  M Engelsgjerd; F A Farraye; R D Odze
Journal:  Gastroenterology       Date:  1999-12       Impact factor: 22.682

5.  Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps.

Authors:  P H Rubin; S Friedman; N Harpaz; E Goldstein; J Weiser; J Schiller; J D Waye; D H Present
Journal:  Gastroenterology       Date:  1999-12       Impact factor: 22.682

6.  EUS to detect evidence of pancreatic disease in patients with persistent or nonspecific dyspepsia.

Authors:  A V Sahai; G Mishra; I D Penman; D Williams; M B Wallace; N Hadzijahic; A Pearson; A Vanvelse; B J Hoffman; R H Hawes
Journal:  Gastrointest Endosc       Date:  2000-08       Impact factor: 9.427

7.  Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy.

Authors:  M O Blackstone; R H Riddell; B H Rogers; B Levin
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

8.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.

Authors:  R H Riddell; H Goldman; D F Ransohoff; H D Appelman; C M Fenoglio; R C Haggitt; C Ahren; P Correa; S R Hamilton; B C Morson
Journal:  Hum Pathol       Date:  1983-11       Impact factor: 3.466

9.  Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis.

Authors:  T A Brentnall; R C Haggitt; P S Rabinovitch; M B Kimmey; M P Bronner; D S Levine; K V Kowdley; A C Stevens; D A Crispin; M Emond; C E Rubin
Journal:  Gastroenterology       Date:  1996-02       Impact factor: 22.682

10.  Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years.

Authors:  J E Lennard-Jones; D M Melville; B C Morson; J K Ritchie; C B Williams
Journal:  Gut       Date:  1990-07       Impact factor: 23.059
View more
  86 in total

1.  Ten year follow up of ulcerative colitis patients with and without low grade dysplasia.

Authors:  C H Lim; M F Dixon; A Vail; D Forman; D A F Lynch; A T R Axon
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

2.  Risk of ulcerative colitis-associated colorectal cancer in China: a multi-center retrospective study.

Authors:  Wei Gong; Nonghua Lv; Bangmao Wang; Ye Chen; Yinglong Huang; Wenshen Pan; Bo Jiang
Journal:  Dig Dis Sci       Date:  2011-09-22       Impact factor: 3.199

3.  Target biopsy or step biopsy? Optimal surveillance for ulcerative colitis: a Japanese nationwide randomized controlled trial.

Authors:  Toshiaki Watanabe; Yoichi Ajioka; Takayuki Matsumoto; Naoki Tomotsugu; Toru Takebayashi; Eisuke Inoue; Bunei Iizuka; Masahiro Igarashi; Yasushi Iwao; Kazuo Ohtsuka; Shin-ei Kudo; Kiyonori Kobayashi; Miwa Sada; Takayuki Matsumoto; Ichiro Hirata; Kazunari Murakami; Masakazu Nagahori; Kenji Watanabe; Nobuyuki Hida; Fumiaki Ueno; Shinji Tanaka; Mamoru Watanabe; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2010-11-02       Impact factor: 7.527

4.  p53 mutations are associated with dysplasia and progression of dysplasia in patients with Crohn's disease.

Authors:  Jeffrey W Nathanson; Nicole E Yadron; Jeanne Farnan; Sydney Kinnear; John Hart; David T Rubin
Journal:  Dig Dis Sci       Date:  2007-08-04       Impact factor: 3.199

5.  Simultaneous detection of synchronous colonic and biliary carcinoma by abdominal ultrasonography in two patients with ulcerative colitis.

Authors:  R D Klingenberg-Noftz; N Homann; I Bos; H P Bruch; D Ludwig
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

6.  British Society of Gastroenterology guidelines for ulcerative colitis surveillance: creating consensus or confusion?

Authors:  B Hudson; J Green
Journal:  Gut       Date:  2006-07       Impact factor: 23.059

7.  Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn's colitis.

Authors:  D H Johnson; S Khanna; T C Smyrk; E V Loftus; K S Anderson; D W Mahoney; D A Ahlquist; J B Kisiel
Journal:  Aliment Pharmacol Ther       Date:  2014-04-30       Impact factor: 8.171

8.  Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists.

Authors:  Brennan M R Spiegel; Wayne Ho; Eric Esrailian; Stephan Targan; Peter D R Higgins; Corey A Siegel; Marla Dubinsky; Gil Y Melmed
Journal:  Clin Gastroenterol Hepatol       Date:  2008-09-04       Impact factor: 11.382

9.  Preoperative evaluation and oncologic principles of colon cancer surgery.

Authors:  Matthew L Lynch; Marc I Brand
Journal:  Clin Colon Rectal Surg       Date:  2005-08

Review 10.  Endoscopic and pathological aspects of colitis-associated dysplasia.

Authors:  Fiona D M van Schaik; G Johan A Offerhaus; Marguerite E I Schipper; Peter D Siersema; Frank P Vleggaar; Bas Oldenburg
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-09-22       Impact factor: 46.802
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.